Portland, OR – According to filings with the U.S. Securities and Exchange Commission, Phylos Bioscience is raising $26,000,000.00 in a new round of investment. Sources indicate as part of senior management Chief Financial Officer, Scott Bowman played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Phylos Bioscience

Phylos is an agricultural genomics company using modern molecular genetics and computational biology to power the next generation of hemp and cannabis. Phylos provides breeding and R&D services to global partners and offers a suite of genetic services and testing solutions. We remain committed to a sustainable cannabis industry and to the preservation of genetic diversity through the Phylos Galaxy and publicly accessible data, like the Open Cannabis Project. We are a new generation of plant scientists, transforming the hemp and cannabis industries with unparalleled data, technology, and expertise. Phylos is strategically positioned to provide cultivators with the tools to understand the breadth of genetics in their catalog, evaluate development of additional varieties, and drive business growth. To learn more about Phylos Bioscience, visit http://www.phylosbioscience.com/

Contact:
Scott Bowman, Chief Financial Officer
503-206-6599
sbowman@phylosbioscience.com
https://www.linkedin.com/in/scottcbowman/

SOURCE: http://www.intelligence360.io
Copyright (c) 2019 SI360 Inc. All rights reserved